EC Number |
Title |
Organism |
---|
2.7.7.23 | A missense mutation in a patient with developmental delay affects the activity and structure of the hexosamine biosynthetic pathway enzyme AGX1 |
Homo sapiens |
2.7.7.23 | Action of dicumarol on glucosamine-1-phosphate acetyltransferase of GlmU and Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
2.7.7.23 | Classification, characterization and structural analysis of sugar nucleotidylyltransferase family of enzymes |
Candida albicans |
2.7.7.23 | Classification, characterization and structural analysis of sugar nucleotidylyltransferase family of enzymes |
Mycobacterium tuberculosis |
2.7.7.23 | Classification, characterization and structural analysis of sugar nucleotidylyltransferase family of enzymes |
Mycobacterium tuberculosis H37Rv |
2.7.7.23 | Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU) inhibitory activity of terreic acid isolated from Aspergillus terreus |
Escherichia coli |
2.7.7.23 | Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU) inhibitory activity of terreic acid isolated from Aspergillus terreus |
Escherichia coli ATCC 25922 |
2.7.7.23 | Exploring MDR-TB inhibitory potential of 4-aminoquinazolines as Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmUMTB) inhibitors |
Mycobacterium tuberculosis |
2.7.7.23 | Exploring MDR-TB inhibitory potential of 4-aminoquinazolines as Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmUMTB) inhibitors |
Mycobacterium tuberculosis H37Rv |
2.7.7.23 | Exploring MDR-TB inhibitory potential of 4-aminoquinazolines as Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmUMTB) inhibitors |
Mycobacterium tuberculosis ATCC 25618 |